ACRAF SpA (Gruppo Angelini)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ACRAF SpA (Gruppo Angelini)
The two companies signed a development and commercialization deal with a $200m upfront payment and milestones of up to $4.3bn.
Shuttle Pharmaceuticals and PaxMedica launch two small initial public offerings in the US as the market awaits a significant IPO. Also, Assertio closed a $70m follow-on offering, Codiak restructures and cuts jobs, and Vilya emerges with $50m in series A venture capital.
The company plans to seek an EUA in Vietnam for ARCT-154, but some analysts have questioned its prospects in major markets like the US.
Public Company Edition: Lilly’s COVID-19 antibody partner AbCellera launched one of the biggest IPOs of 2020, bringing in $483m. Also, two more SPACs went public; Sinovac, Biocryst and Kura Oncology arranged large financings; and Viatris plans post-merger layoffs.